HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiuli Ma Selected Research

Laryngo onycho cutaneous syndrome

3/2022[A pedigree study of laryngo-onycho-cutaneous syndrome with a novel mutation on LAMA3 gene].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiuli Ma Research Topics

Disease

5Infections
01/2022 - 10/2014
5Human Influenza (Influenza)
12/2021 - 10/2014
5Breast Neoplasms (Breast Cancer)
03/2019 - 01/2013
4Neoplasms (Cancer)
01/2022 - 05/2013
3Virus Diseases (Viral Diseases)
10/2021 - 01/2019
1Waardenburg Syndrome (Klein Syndrome)
05/2022
1Deafness (Deaf Mutism)
05/2022
1Sensorineural Hearing Loss
05/2022
1Laryngo onycho cutaneous syndrome
03/2022
1Hepatitis D
01/2022
1Duane Retraction Syndrome (Duane Syndrome)
01/2022
1Stomach Neoplasms (Stomach Cancer)
09/2019
1Carcinoma (Carcinomatosis)
09/2019
1Body Weight (Weight, Body)
01/2019
1Hepatocellular Carcinoma (Hepatoma)
01/2019
1Obesity
01/2019
1Type 2 Diabetes Mellitus (MODY)
01/2019
1Retinal Degeneration
01/2019
1Hyperglycemia
01/2019
1Dwarfism
01/2016
1Atrophy
01/2016
1Hepatitis A (Hepatitis, Infectious)
04/2015
1Inflammation (Inflammations)
07/2009
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2008
1Hypoxia (Hypoxemia)
05/2007
1Stroke (Strokes)
05/2007
1Mitochondrial Diseases (Mitochondrial Disease)
03/2007

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
12/2019 - 05/2013
4Oseltamivir (Tamiflu)FDA Link
12/2021 - 10/2014
4Claudin-1IBA
03/2019 - 05/2013
3DNA (Deoxyribonucleic Acid)IBA
03/2022 - 01/2022
3Neuraminidase (Sialidase)IBA
12/2021 - 10/2014
3Tight Junction ProteinsIBA
03/2019 - 01/2015
3Pharmaceutical PreparationsIBA
01/2019 - 07/2018
2Biological ProductsIBA
03/2022 - 01/2022
2RNA (Ribonucleic Acid)IBA
01/2022 - 05/2007
2Antiviral Agents (Antivirals)IBA
12/2021 - 10/2021
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 03/2007
2CalciumIBA
01/2019 - 01/2013
2Cisplatin (Platino)FDA LinkGeneric
08/2015 - 01/2015
2Phenobarbital (Luminal)FDA Link
08/2015 - 01/2015
2TamoxifenFDA LinkGeneric
08/2015 - 01/2015
2Etoposide (VP 16)FDA LinkGeneric
08/2015 - 01/2015
1Catalytic RNA (Ribozymes)IBA
01/2022
1NucleosidesIBA
10/2021
1plumbaginIBA
09/2019
1adenanthinIBA
01/2019
1DiterpenesIBA
01/2019
1Kaurane DiterpenesIBA
01/2019
1Selective Estrogen Receptor Modulators (SERM)IBA
01/2019
1Raloxifene Hydrochloride (Evista)FDA Link
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1Glucose Transporter Type 4IBA
01/2019
1benzothiopheneIBA
01/2019
1nasIBA
07/2018
1Synthetic CathinoneIBA
01/2016
1benzoylamido- 4'- aminostilbene- 2,2'- disulfonate (BADS)IBA
01/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2015
1AntigensIBA
04/2015
1Viral ProteinsIBA
04/2015
1AntibodiesIBA
04/2015
1EnzymesIBA
04/2015
1OsteopontinIBA
05/2013
1IonsIBA
01/2013
1Plasminogen Activators (Plasminogen Activator)IBA
07/2009
1Biomarkers (Surrogate Marker)IBA
10/2008
1Triglycerides (Triacylglycerol)IBA
10/2008
1VLDL LipoproteinsIBA
10/2008

Therapy/Procedure

1Cochlear Implants (Cochlear Implant)
05/2022
1Cochlear Implantation
05/2022
1Electrodes (Electrode)
01/2013